China’s oil giants Sinopec, CNAF to undergo consolidation, creating energy powerhouse


Beijing has given the green light to an asset-restructuring deal involving the country’s largest oil refiner and a leading distributor of jet fuel, continuing efforts to streamline operations of major state-owned juggernauts.

China Petroleum and Chemical Corp, better known as Sinopec, and China National Aviation Fuel Group (CNAF) will conduct a revamp of their assets after receiving the nod from the State Council, the State-owned Assets Supervision and Administration Commission (SASAC) said in a statement on Thursday.

It did not provide details about the reorganisation between the two companies. In mainland China, asset restructuring between two state-owned giants is synonymous with a merger.

“The state-asset regulator is looking to orchestrate more consolidation deals to strengthen the financial muscle and operating efficiency of big companies in some important industries,” said Wang Feng, chairman of Ye Lang Capital, a Shang­hai-based financial services group. “A merger between the two firms will create a more vertically integrated oil empire.”

China National Aviation Fuel Group controls the refuelling network at mainland China’s airports. Photo: Handout via Xinhua
China National Aviation Fuel Group controls the refuelling network at mainland China’s airports. Photo: Handout via Xinhua

Sinopec processes crude into oil products, including jet fuel – supplying it to CNAF, which controls the refuelling network at mainland China’s airports.

  • Related Posts

    India raises export tax on diesel, jet fuel by Rs 7/litre as crude prices spike; cuts petrol levy – Firstpost

    India has raised windfall taxes on exports of diesel and aviation turbine fuel (ATF) by Rs 7 per litre each, while cutting the levy on petrol exports, as global crude…

    Continue reading
    India’s Sun Pharma gets South Africa nod for generic semaglutide after Novo Nordisk patent expiry – Firstpost

    India’s Sun Pharmaceutical Industries has received approval from South Africa’s health regulator to manufacture and sell a generic version of semaglutide, the active ingredient used in Novo Nordisk’s blockbuster diabetes…

    Continue reading

    Leave a Reply

    Your email address will not be published. Required fields are marked *